Skip to main content

Mesa Laboratories, Inc.

corporate_fare Company Profile

Mesa Laboratories, Inc.

MLAB·NASDAQ·Life Sciences·CIK 0000724004

MESA LABORATORIES INC is a global leader in the design and manufacture of life sciences tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare, and medical device industries. The company provides products and services to help customers ensure product integrity, increase patient and worker safety, and improve quality of life. MESA LABORATORIES INC has manufacturing operations in the United States and Europe. Its products are marketed by sales personnel in North America, Europe, and the Asia Pacific region ("APAC"), and by independent distributors worldwide. The company is headquartered in Lakewood, Colorado, and its common stock trades on the Nasdaq Global Market ("Nasdaq") under the symbol MLAB. Its fiscal year ends on March 31. Revenues are derived from sales of products and services. Product sales primarily consist of consumables and hardware. Services primarily consist of discrete and ongoing maintenance, calibration, and testing services. The company grows revenues organically by expanding its customer base and product offerings, increasing sales volumes, and implementing price increases. It also grows inorganically through acquisitions, focusing on businesses that complement its existing portfolio and expand its global presence further into life sciences tools and critical quality control solutions markets for regulated applications. MESA LABORATORIES INC aims to maximize value by implementing efficiencies in its manufacturing, commercial, engineering, and administrative operations.

Mesa Laboratories, Inc. (NASDAQ:MLAB) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 16 items for MLAB at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-09, rated 7/10. Across its 16 most recent items scored 7 or higher, the top rating is 8/10, with 4 rated 8 or above. Recent SEC coverage for MLAB spans 8-K, 10-Q, 4, 10-K.

Recent high-impact activity:

  • Mesa Labs Posts 75c Q2 EPS as Operating Income Jumps 78%
  • Mesa Labs Issues First-Ever FY27 Guidance: $250-255M Revenue, $66-68M Adjusted EBITDA
  • Mesa Labs Q2 Operating Income Jumps 78% to $8.4M; Board Authorizes New $40M Buyback
  • Mesa Labs Restructures Clinical Genomics, Cuts 40 Jobs to Save $9.3M Annually
  • Mesa Labs Cuts 6% of Workforce, Targets $5M Net Annual Savings

Financial Snapshot

Fiscal year ended March 31, 2026
Revenue
$249.13M
Net Income
$6.71M
Diluted EPS
$1.21
Op. Cash Flow
$42.83M
Free Cash Flow
$39.58M
Gross Profit
$158.27M
Operating Income
$18.51M
Cash & Equivalents
$26.93M
Total Debt
$67.5M
Debt / Equity
0.36×
Net Margin
2.7%
Shares Outstanding
5.52M sh
Source: 10-K · filed 2026-06-02 · accession 0000724004-26-000047

Short Interest & Short Volume

4.68 days to cover

FINRA reported short interest of 377,163 shares in MLAB as of the October 30, 2026 settlement, a 3.4% decrease from the prior period — about 4.7 days to cover at its recent average daily volume. On November 20, 2026, 69.9% of MLAB volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)377,163 shares as of October 30, 2026
Change vs prior period▼ 3.4%
Days to cover4.68 at avg daily volume of 80,558
Daily short volume (FINRA facilities)69.9% of 21,168 shares on November 20, 2026
5-day average short volume68.1%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with M →
$127.93
52-week range · as of 2026-11-09 $69.51 – $144.35
Market cap
$719.03M
Volume
76K (0.7× avg)
3-mo avg 102.1K
Live data · 2026-11-21 23:06 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed MLAB - Latest Insights

MLAB
Nov 09, 2026, 4:40 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $122.00
Real-time Price: $127.93 info
Change: +$5.93 (+5%) info
Market Cap: $719.033M info
MLAB
Nov 09, 2026, 4:35 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $122.00
Real-time Price: $127.93 info
Change: +$5.93 (+5%) info
Market Cap: $719.033M info
MLAB
Nov 09, 2026, 4:16 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $122.00
Real-time Price: $127.93 info
Change: +$5.93 (+5%) info
Market Cap: $719.033M info
MLAB
Oct 13, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $128.07
Real-time Price: $127.93 info
Change: -$0.140 (-0.11%) info
Market Cap: $719.033M info
MLAB
Oct 13, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $128.07
Real-time Price: $127.93 info
Change: -$0.140 (-0.11%) info
Market Cap: $719.033M info
MLAB
Aug 17, 2026, 11:49 AM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $108.36
Real-time Price: $127.93 info
Change: +$19.57 (+18%) info
Market Cap: $719.033M info
MLAB
Aug 10, 2026, 5:17 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $101.62
Real-time Price: $127.93 info
Change: +$26.31 (+26%) info
Market Cap: $719.033M info
MLAB
Aug 10, 2026, 4:12 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $101.62
Real-time Price: $127.93 info
Change: +$26.31 (+26%) info
Market Cap: $719.033M info
MLAB
Jun 15, 2026, 5:29 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $104.08
Real-time Price: $127.93 info
Change: +$23.85 (+23%) info
Market Cap: $719.033M info
MLAB
Jun 02, 2026, 6:19 PM EDT
Filing Type: 10-K
Importance Score:
7
Price at Filing: $104.53
Real-time Price: $127.93 info
Change: +$23.40 (+22%) info
Market Cap: $719.033M info
MLAB
May 28, 2026, 3:14 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $90.76
Real-time Price: $127.93 info
Change: +$37.17 (+41%) info
Market Cap: $719.033M info
MLAB
May 27, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $104.00
Real-time Price: $127.93 info
Change: +$23.93 (+23%) info
Market Cap: $719.033M info
MLAB
Mar 23, 2026, 4:25 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $82.03
Real-time Price: $127.93 info
Change: +$45.90 (+56%) info
Market Cap: $719.033M info
MLAB
Mar 09, 2026, 5:02 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $87.69
Real-time Price: $127.93 info
Change: +$40.24 (+46%) info
Market Cap: $719.033M info
MLAB
Feb 03, 2026, 8:01 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $85.00
Real-time Price: $127.93 info
Change: +$42.93 (+51%) info
Market Cap: $719.033M info
MLAB
Feb 03, 2026, 8:00 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $82.10
Real-time Price: $127.93 info
Change: +$45.83 (+56%) info
Market Cap: $719.033M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets